• This study identifies a calmodulin-binding sequence in Sema4D and shows that calmodulin binds to Sema4D in resting platelets.• Dissociation of the Sema4D:calmodulin complex is sufficient to trigger Sema4D cleavage and shedding of the extracellular domain.Semaphorin 4D (Sema4D) is a transmembrane protein that supports contact-dependent amplification of platelet activation by collagen before being gradually cleaved by the metalloprotease ADAM17, as we have previously shown. Cleavage releases a soluble 120-kDa exodomain fragment for which receptors exist on platelets and endothelial cells. Here we have examined the mechanism that regulates Sema4D exodomain cleavage. The results show that the membrane-proximal cytoplasmic domain of Sema4D contains a binding site for calmodulin within the polybasic region Arg762-Lys779. Coprecipitation studies show that Sema4D and calmodulin are associated in resting platelets, forming a complex that dissociates upon platelet activation by the agonists that trigger Sema4D cleavage. Inhibiting calmodulin with W7 or introducing a membrane-permeable peptide corresponding to the calmodulin-binding site is sufficient to trigger the dissociation of Sema4D from calmodulin and initiate cleavage. Conversely, deletion of the calmodulin-binding site causes constitutive shedding of Sema4D. These results show that (1) Sema4D is a calmodulin-binding protein with a site of interaction in its membrane-proximal cytoplasmic domain, (2) platelet agonists cause dissociation of the calmodulin-Sema4D complex, and (3) dissociation of the complex is sufficient to trigger ADAM17-dependent cleavage of Sema4D, releasing a bioactive fragment. (Blood. 2013;121(20):4221-4230) Introduction Sema4D (CD100), a class IV semaphorin family member, is a 150-kDa type I membrane glycoprotein. The mature protein is a disulfidelinked homodimer that includes an NH 2 -terminal (N-terminal) sema domain and a cytoplasmic domain containing sites for tyrosine and serine and/or threonine phosphorylation.1-5 Sema4D was first described on T cells where it supports B-cell differentiation by binding to the low-affinity receptor CD72. 3,[6][7][8] Subsequent studies have identified roles for Sema4D in axon guidance, 9-12 angiogenesis, [13][14][15][16][17] and tumor progression [18][19][20] and showed that some of these effects are mediated by the high-affinity receptor plexin-B1 20 and the related lower-affinity receptor plexin-B2. 21,22 In previously published studies, we have shown that Sema4D is expressed by platelets and that it participates in the hemostatic response to injury by reinforcing collagen-initiated platelet activation in a contact-dependent manner.23,24 Deletion of Sema4D protects mice against the development of atherosclerosis by attenuating platelet hyperactivity in the setting of hyperlipidemia 25 and reducing intimal neovascularization, 26 which suggests that platelet Sema4D has an impact on the vessel wall as well as on platelets. Our previous studies also showed that the extracellular domain of Sema4D is gradu...